Galderma sues Mylan over Oracea patents
This article was originally published in Scrip
Executive Summary
Galderma Laboratories is suing Mylan Laboratories for alleged patent infringement related to Mylan's US ANDA for the rosacea treatment Oracea (doxycycline) delayed-release capsules 40mg.